Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...

CHANGE-seq-BE was developed to enable scientists to better understand base editors, an important class of CRISPR precise genome editors.

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

Find how Circularization for High-throughput Analysis of Nuclease Genome-wide Effects by Sequencing Base Editors ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Imagine a humanoid robot with not two, but six arms, as if it had dropped straight out of Indian mythology. This is the MIRO ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Looking back at the performance of ARK Invest, led by Cathie Wood (“Cathie Wood”), in 2025, despite reducing its holdings of Tesla (TSLA) by over 633,000 shares during the ...